Good Results and better commentary on future growth prospects by management. Growth in high margin CDMO business and future capacity utilizations are likely to result in stock moving above its IPO price in coming months. Only overhang is parent company stake sale and new management rumors.
Current margins and future growth makes current PE around 16 very attractive and a PE re rating to 25 likely in coming one year.
My views are biased as I am invested from lower levels.
| Subscribe To Our Free Newsletter |
